drugset / Trial / NCT04621409
LEAP2 on Postprandial Glucose Metabolism and Food Intake
RandomizedCrossoverDouble-blindTreatment
Summary
The study aim to delineate the effects of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) on postprandial glucose metabolism and food intake in healthy volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in healthy subjects.
Timeline
- Start
- 2020-11-17
- Primary completion
- 2021-02-18
- Completion
- 2021-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEAP2 | Peptide | — | Intravenous |